Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Fairbanks Institute for Healthy Communities was an Indianapolis-based non-profit organization dedicated to advancing personalized medicine through the creation of a large-scale biorepository called INbank. Launched in 2006 with support from BioCrossroads and the Richard M. Fairbanks Foundation, the institute collected biological samples and longitudinal clinical data from the Indiana population, specifically focusing on chronic diseases like type 2 diabetes and coronary artery disease. By linking these samples to electronic health records from the Indiana Network for Patient Care (INPC), the institute provided a unique platform for researchers in academia and industry to study disease progression and treatment response. Although it is no longer active as an independent entity, its contributions to biobanking and the Indiana life sciences ecosystem provided critical resources for biomarker discovery and translational research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fairbanks Institute.